Sales & Marketing Business strategy and forecasting team: Ally or adversary? It’s 2023 and pharma is moving ahead and leaving behind the COVID-19 aftermath.
Market Access Sponsored The changing face of pharmaceutical launches The industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues to evolve, with significant ramifications for new pharmaceutical launches.<
News Novo Nordisk Foundation gives $75m for R&D 'challenges' The Novo Nordisk Foundation's latest round of R&D funding will go towards projects in biomanufacturing, cardiometabolic diseases, and AI.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
